Application 019046

Type
NDA
Sponsor
SCHERING

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NORMOZIDEHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDETABLET;ORAL25MG;100MGNoNo
002NORMOZIDEHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDETABLET;ORAL25MG;200MGNoNo
003NORMOZIDEHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDETABLET;ORAL25MG;300MGNoNo
004NORMOZIDEHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDETABLET;ORAL25MG;400MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N019046-001NORMOZIDEHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE25MG;100MGTABLET / ORAL1987-04-06
N019046-002NORMOZIDEHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE25MG;200MGTABLET / ORAL1987-04-06
N019046-003NORMOZIDEHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE25MG;300MGTABLET / ORAL1987-04-06
N019046-004NORMOZIDEHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE25MG;400MGTABLET / ORAL1987-04-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 5 of 5 · 180 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N019046-001NORMOZIDE25MG;100MGTABLET / ORAL1987-04-063a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N019046-002NORMOZIDE25MG;200MGTABLET / ORAL1987-04-063a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N019046-003NORMOZIDE25MG;300MGTABLET / ORAL1987-04-063a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N019046-004NORMOZIDE25MG;400MGTABLET / ORAL1987-04-063a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N019046-001NORMOZIDE25MG;100MGTABLET / ORAL1987-04-06f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N019046-002NORMOZIDE25MG;200MGTABLET / ORAL1987-04-06f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N019046-003NORMOZIDE25MG;300MGTABLET / ORAL1987-04-06f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N019046-004NORMOZIDE25MG;400MGTABLET / ORAL1987-04-06f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N019046-001NORMOZIDE25MG;100MGTABLET / ORAL1987-04-06e64feba35796…
2022-09-29 23:25 UTC2022-09N019046-002NORMOZIDE25MG;200MGTABLET / ORAL1987-04-06e64feba35796…
2022-09-29 23:25 UTC2022-09N019046-003NORMOZIDE25MG;300MGTABLET / ORAL1987-04-06e64feba35796…
2022-09-29 23:25 UTC2022-09N019046-004NORMOZIDE25MG;400MGTABLET / ORAL1987-04-06e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N019046-001NORMOZIDE25MG;100MGTABLET / ORAL1987-04-06cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N019046-002NORMOZIDE25MG;200MGTABLET / ORAL1987-04-06cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N019046-003NORMOZIDE25MG;300MGTABLET / ORAL1987-04-06cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N019046-004NORMOZIDE25MG;400MGTABLET / ORAL1987-04-06cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N019046-001NORMOZIDE25MG;100MGTABLET / ORAL1987-04-06a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N019046-002NORMOZIDE25MG;200MGTABLET / ORAL1987-04-06a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N019046-003NORMOZIDE25MG;300MGTABLET / ORAL1987-04-06a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N019046-004NORMOZIDE25MG;400MGTABLET / ORAL1987-04-06a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.